Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 948046 FRANKFURT AM MAIN, 2M
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$407,524
+$162,566 QoQ
Shares Held
27,951
+44.1% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 122 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. ENTA ranks #193 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in ENTA

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $407,524 27,951
2026-03-31 $244,958 19,395
2025-12-31 $380,167 24,107
2025-09-30 $275,932 23,052
2024-09-30 $108,075 10,432
2024-06-30 $82,242 6,341
2024-03-31 $186,943 10,707
2023-12-31 $95,755 10,176
2023-09-30 $115,776 10,365
2023-06-30 $192,214 8,982
2023-03-31 $603,930 14,934
2022-12-31 $499,531 10,738
2022-09-30 $442,657 8,534
2022-06-30 $463,576 9,807
2022-03-31 $779,206 10,947
2021-12-31 $3,151,152 42,139
2021-09-30 $3,773,714 66,427
2021-06-30 $2,799,518 63,611
2021-03-31 $4,060,860 82,337
2020-12-31 $2,931,211 69,625
2020-09-30 $533,656 11,657
2020-06-30 $7,132,580 142,055
2020-03-31 $13,478,361 262,072